Chinook Therapeutics Inc. (KDNY) NASDAQ

$40.39 - (-)

Market Cap: -

As of 08/10/23 12:00 AM EDT. Market closed.

(KDNY)

Chinook Therapeutics Inc. (KDNY)
NASDAQ

$40.39
- (-)

Market Cap: -

As of 08/10/23 12:00 AM EDT. Market closed.

Add to Portfolio

chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. drug development in kidney diseases is experiencing a resurgence due to greater ... read more

chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. drug development in kidney diseases is experiencing a resurgence due to greater understanding of disease biology, utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
740 Heinz Ave, California, Berkeley, 94710-2748.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Stephen Isaacs
Address
740 Heinz Ave, California, Berkeley, 94710-2748.
PRICE CHART FOR CHINOOK THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$40.39
Days Range
$40.30 - $40.51
52 week range
- - -
Volume
4,924,994
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
71,804,977
Open
-
Previous Close
$40.39
Days Range
$40.30 - $40.51
52 week range
- - -
Volume
4,924,994
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
71,804,977
FINANCIAL STATEMENTS FOR CHINOOK THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CHINOOK THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
King Andrew JamesChief Scientific OfficerAug 01, 2023 Sale$39.031,16845,58619,157Aug 01, 2023, 07:27 PM
Greenman William MarinerDirectorMay 30, 2023 Sale$23.301,15526,91123,643May 31, 2023, 07:26 PM
DOBMEIER ERICPresident, CEOApr 24, 2023 Option Exercise$0.4225,00010,500326,138Apr 26, 2023, 05:19 PM
DOBMEIER ERICPresident, CEOApr 24, 2023 Sale$21.6125,000540,239302,338Apr 26, 2023, 05:19 PM
Jerel DavisDirectorApr 17, 2023 Sale$20.75295,8086,138,223443,713Apr 19, 2023, 05:58 PM
King Andrew JamesChief Scientific OfficerApr 03, 2023 Option Exercise$0.352,50087521,992Apr 05, 2023, 04:43 PM
King Andrew JamesChief Scientific OfficerApr 03, 2023 Sale$23.345,000116,71816,992Apr 05, 2023, 04:43 PM
Krishnan MaheshDirectorApr 04, 2023 Sale$23.0192421,2611,275Apr 04, 2023, 09:14 PM
Jerel DavisDirectorMar 01, 2023 Sale$22.75400,0009,100,0002,105,107Mar 03, 2023, 04:13 PM
BJERKHOLT ERICChief Financial OfficerFeb 10, 2023 Sale$23.7585720,35238,867Feb 15, 2023, 04:41 PM
DOBMEIER ERICPresident, CEOFeb 10, 2023 Sale$23.758,097192,292301,138Feb 15, 2023, 04:40 PM
Frohlich TomChief Operating OfficerFeb 10, 2023 Sale$23.753,70087,869150,777Feb 15, 2023, 04:40 PM
King Andrew JamesChief Scientific OfficerFeb 10, 2023 Sale$23.752,39256,80619,492Feb 15, 2023, 04:39 PM
Frohlich TomChief Operating OfficerJan 31, 2023 Sale$24.684,566112,700147,674Feb 02, 2023, 06:15 PM
BJERKHOLT ERICChief Financial OfficerJan 31, 2023 Sale$24.682,89171,35737,289Feb 02, 2023, 06:14 PM
King Andrew JamesChief Scientific OfficerJan 31, 2023 Sale$24.683,24480,06915,081Feb 02, 2023, 06:13 PM
DOBMEIER ERICPresident, CEOJan 30, 2023 Option Exercise$0.4225,00010,500296,676Feb 01, 2023, 08:32 PM
DOBMEIER ERICPresident, CEOJan 31, 2023 Sale$24.687,688189,757288,987Feb 01, 2023, 08:32 PM
DOBMEIER ERICPresident, CEOJan 30, 2023 Sale$24.5425,000613,613271,676Feb 01, 2023, 08:32 PM
King Andrew JamesChief Scientific OfficerJan 03, 2023 Option Exercise$0.357,5002,62519,992Jan 04, 2023, 07:44 PM
King Andrew JamesChief Scientific OfficerJan 03, 2023 Sale$25.8210,000258,1839,992Jan 04, 2023, 07:44 PM
Frohlich TomChief Operating OfficerDec 13, 2022 Option Exercise$0.4210,0004,200153,907Dec 15, 2022, 04:28 PM
Frohlich TomChief Operating OfficerDec 13, 2022 Sale$25.0010,000250,005143,907Dec 15, 2022, 04:28 PM
DOBMEIER ERICPresident, CEODec 14, 2022 Option Exercise$0.3530,00010,500271,676Dec 15, 2022, 04:27 PM
DOBMEIER ERICPresident, CEODec 01, 2022 Option Exercise$0.4260,00025,200271,676Dec 02, 2022, 04:26 PM
DOBMEIER ERICPresident, CEODec 01, 2022 Sale$22.3130,000669,351241,676Dec 02, 2022, 04:26 PM
BJERKHOLT ERICChief Financial OfficerDec 01, 2022 Sale$22.295,770128,60232,847Dec 02, 2022, 04:25 PM
Frohlich TomChief Operating OfficerNov 07, 2022 Option Exercise$0.4210,0004,200153,907Nov 09, 2022, 04:21 PM
Frohlich TomChief Operating OfficerNov 07, 2022 Sale$22.1610,000221,642143,907Nov 09, 2022, 04:21 PM
Frohlich TomChief Operating OfficerOct 06, 2022 Sale$19.697,360144,933143,907Oct 11, 2022, 04:33 PM
King Andrew JamesChief Scientific OfficerOct 06, 2022 Sale$19.693,55770,04412,492Oct 11, 2022, 04:32 PM
Thomas DolcaDirectorSep 02, 2022 Buy$21.2210,000212,19410,000Sep 06, 2022, 04:35 PM
King Andrew JamesChief Scientific OfficerAug 04, 2022 Option Exercise$0.355,0001,75010,897Aug 05, 2022, 05:09 PM
King Andrew JamesChief Scientific OfficerAug 04, 2022 Sale$20.005,000100,0005,897Aug 05, 2022, 05:09 PM
King Andrew JamesChief Scientific OfficerJul 11, 2022 Option Exercise$0.355,0001,75010,897Jul 13, 2022, 04:11 PM
King Andrew JamesChief Scientific OfficerJul 11, 2022 Sale$18.095,00090,4685,897Jul 13, 2022, 04:11 PM
AKKARAJU SRINIVASDirectorMay 27, 2022 Buy$14.00570,0007,980,0005,161,888Jun 01, 2022, 04:13 PM
DOBMEIER ERICPresident, CEOMay 25, 2022 Buy$13.035,00065,148205,880May 27, 2022, 06:17 PM
King Andrew JamesChief Scientific OfficerApr 11, 2022 Option Exercise$0.355,0001,75010,897Apr 13, 2022, 05:34 PM
King Andrew JamesChief Scientific OfficerApr 11, 2022 Sale$15.365,00076,8125,897Apr 13, 2022, 05:34 PM
King Andrew JamesChief Scientific OfficerFeb 18, 2022 Sale$13.002,50032,5005,897Feb 23, 2022, 05:17 PM
BJERKHOLT ERICChief Financial OfficerFeb 11, 2022 Sale$12.7489511,40322,203Feb 14, 2022, 07:58 PM
King Andrew JamesChief Scientific OfficerFeb 11, 2022 Sale$12.742,49831,8278,397Feb 14, 2022, 07:56 PM
Glicklich AlanChief Medical OfficerFeb 11, 2022 Sale$12.742,39130,4647,891Feb 14, 2022, 07:56 PM
Frohlich TomChief Operating OfficerFeb 11, 2022 Sale$12.743,73547,587137,685Feb 14, 2022, 07:53 PM
King Andrew JamesChief Scientific OfficerFeb 10, 2022 Option Exercise$0.352,5008756,594Feb 11, 2022, 05:26 PM
King Andrew JamesChief Scientific OfficerFeb 10, 2022 Sale$13.312,50033,2754,094Feb 11, 2022, 05:26 PM
Versant Venture Capital VII, L.P.10% OwnerJan 03, 2022 Sale$16.00400,0006,400,0801,863,197Jan 05, 2022, 05:16 PM
Versant Venture Capital VII, L.P.10% OwnerJan 03, 2022 Sale$16.00600,0009,600,1203,623,023Jan 05, 2022, 05:16 PM
Jerel DavisDirectorJan 03, 2022 Sale$16.001,000,00016,000,2003,623,023Jan 05, 2022, 05:13 PM
DOBMEIER ERICPresident, CEODec 23, 2021 Option Exercise$0.3540,00014,000180,633Dec 27, 2021, 06:24 PM
BJERKHOLT ERICChief Financial OfficerDec 01, 2021 Option Exercise$16.025,75092,09720,664Dec 03, 2021, 07:05 PM
AKKARAJU SRINIVASDirectorNov 15, 2021 Buy$14.001,215,00017,010,0004,591,888Nov 17, 2021, 12:05 PM
Frohlich TomChief Operating OfficerNov 10, 2021 Sale$15.486,23096,440134,619Nov 12, 2021, 08:00 PM
King Andrew JamesChief Scientific OfficerNov 09, 2021 Option Exercise$0.352,5008759,094Nov 12, 2021, 07:59 PM
King Andrew JamesChief Scientific OfficerNov 09, 2021 Sale$13.535,00067,6604,094Nov 12, 2021, 07:59 PM
Frohlich TomChief Operating OfficerNov 05, 2021 Option Exercise$0.4215,0006,300174,619Nov 09, 2021, 09:40 PM
Frohlich TomChief Operating OfficerNov 05, 2021 Sale$14.0020,000280,000159,619Nov 09, 2021, 09:40 PM
Frohlich TomChief Operating OfficerNov 08, 2021 Sale$15.1713,770208,938140,849Nov 09, 2021, 09:40 PM
Greenman William MarinerDirectorOct 21, 2021 Option Exercise$2.601,6634,32421,498Oct 22, 2021, 06:47 PM
Frohlich TomChief Operating OfficerOct 06, 2021 Option Exercise$12.377,35991,021159,619Oct 08, 2021, 06:51 PM
King Andrew JamesChief Scientific OfficerOct 06, 2021 Option Exercise$12.373,55743,9956,594Oct 08, 2021, 06:48 PM
Glicklich AlanChief Medical OfficerOct 06, 2021 Option Exercise$12.372,48930,7854,614Oct 08, 2021, 06:46 PM
Frohlich TomChief Operating OfficerSep 24, 2021 Option Exercise$0.4220,0008,400153,398Sep 28, 2021, 04:46 PM
Frohlich TomChief Operating OfficerSep 24, 2021 Sale$13.0020,000260,000133,398Sep 24, 2021, 08:16 PM
DOBMEIER ERICPresident, CEOSep 20, 2021 Buy$12.002,00024,000109,837Sep 22, 2021, 07:23 PM
Jerel DavisDirectorAug 27, 2021 Sale$14.00850,00011,900,0004,223,023Aug 31, 2021, 07:06 PM
Versant Venture Capital VII, L.P.10% OwnerAug 27, 2021 Sale$14.00340,0004,760,0002,171,197Aug 31, 2021, 07:06 PM
Versant Venture Capital VII, L.P.10% OwnerAug 27, 2021 Sale$14.00510,0007,140,0004,223,023Aug 31, 2021, 07:06 PM
AKKARAJU SRINIVASDirectorAug 18, 2021 Buy$11.98208,5002,497,8303,376,888Aug 20, 2021, 05:37 PM
DOBMEIER ERICPresident, CEOAug 19, 2021 Buy$12.003,00036,000107,837Aug 19, 2021, 05:55 PM
DOBMEIER ERICPresident, CEOAug 18, 2021 Buy$11.747,00082,163104,837Aug 19, 2021, 05:55 PM
Glicklich AlanChief Medical OfficerJun 16, 2021 Option Exercise$0.4220,0008,40020,000Jun 17, 2021, 06:40 PM
Glicklich AlanChief Medical OfficerJun 16, 2021 Sale$16.3520,000326,9680Jun 17, 2021, 06:40 PM
DOBMEIER ERICPresident, CEOJun 14, 2021 Option Exercise$0.3520,0007,00097,837Jun 15, 2021, 05:24 PM
DOBMEIER ERICPresident, CEODec 21, 2020 Option Exercise$0.3520,0007,00076,837Dec 22, 2020, 07:47 PM
DOBMEIER ERICPresident, CEODec 09, 2020 Buy$13.072,00026,15056,837Dec 10, 2020, 05:38 PM
DOBMEIER ERICPresident, CEODec 08, 2020 Buy$13.242,00026,48354,837Dec 10, 2020, 05:38 PM
DOBMEIER ERICPresident, CEONov 23, 2020 Buy$13.6792912,69952,837Nov 23, 2020, 07:26 PM
DOBMEIER ERICPresident, CEONov 20, 2020 Buy$13.695717,81751,908Nov 23, 2020, 07:26 PM
DOBMEIER ERICPresident, CEONov 19, 2020 Buy$13.505006,75051,337Nov 23, 2020, 07:26 PM
DOBMEIER ERICPresident, CEONov 11, 2020 Buy$13.752,50034,37550,837Nov 13, 2020, 06:13 PM
DOBMEIER ERICPresident, CEONov 10, 2020 Buy$13.862,00027,72048,337Nov 13, 2020, 06:13 PM
ISAACS STEPHEN TPresident and CEOSep 15, 2020 Sale$2.3932,48177,691279,166Sep 17, 2020, 08:17 PM
Templeman BlaineChief Legal OfficerSep 15, 2020 Sale$2.3912,36929,585121,916Sep 17, 2020, 08:16 PM
Ferber CelesteSVP, GC and SecretarySep 15, 2020 Sale$2.392,3965,73138,687Sep 17, 2020, 08:15 PM
Nuyten Dimitry SAChief Medical OfficerAug 07, 2020 Sale$2.553,5389,0368,462Aug 11, 2020, 04:06 PM
Templeman BlaineChief Legal OfficerAug 07, 2020 Sale$2.557,95120,308134,285Aug 11, 2020, 04:05 PM
Ferber CelesteSVP, GC and SecretaryAug 07, 2020 Sale$2.557,95120,30841,083Aug 11, 2020, 04:04 PM
Greenman William MarinerDirectorMar 18, 2020 Option Exercise$0.4519,8358,92619,835Mar 20, 2020, 05:18 PM
ISAACS STEPHEN TPresident and CEOMar 18, 2020 Option Exercise$0.4521,6189,728311,647Mar 20, 2020, 05:17 PM
van Elsas AndreaChief Scientific OfficerFeb 25, 2020 Sale$3.516,82323,954438,367Feb 26, 2020, 06:58 PM
van Elsas AndreaChief Scientific OfficerJan 03, 2020 Sale$1.1973,31187,108445,190Jan 06, 2020, 06:38 PM
Templeman BlaineChief Legal OfficerDec 12, 2019 Sale$1.161,2641,470117,736Dec 16, 2019, 04:14 PM
Ferber CelesteSVP, GC and SecretaryDec 12, 2019 Sale$1.1640847526,534Dec 16, 2019, 04:13 PM
van Elsas AndreaChief Scientific OfficerDec 12, 2019 Sale$1.162,1922,550518,501Dec 16, 2019, 04:13 PM
ISAACS STEPHEN TPresident and CEODec 12, 2019 Sale$1.165,8976,860290,029Dec 16, 2019, 04:12 PM
Haghighat RossDirectorSep 16, 2019 Option Exercise$0.6455,53935,52787,122Sep 18, 2019, 07:00 PM
Ferber CelesteSVP, GC and SecretarySep 13, 2019 Sale$1.312,4943,25728,044Sep 17, 2019, 06:34 PM
ISAACS STEPHEN TPresident and CEOSep 13, 2019 Sale$1.3131,09840,608295,926Sep 17, 2019, 06:34 PM
van Elsas AndreaChief Scientific OfficerSep 13, 2019 Sale$1.3118,59324,279521,327Sep 17, 2019, 06:33 PM
Templeman BlaineChief Legal OfficerSep 13, 2019 Sale$1.3112,87816,817122,888Sep 17, 2019, 06:32 PM
Ferber CelesteSVP, GC and SecretaryMay 20, 2019 Sale$3.212,0006,41329,436May 22, 2019, 07:04 PM
Lew JenniferChief Financial OfficerMay 01, 2019 Option Exercise$1.2518,60223,306147,299May 03, 2019, 07:17 PM
Lew JenniferChief Financial OfficerMay 01, 2019 Sale$4.2018,60278,136135,155May 03, 2019, 07:17 PM
Lew JenniferChief Financial OfficerApr 08, 2019 Option Exercise$1.2518,60123,305147,299Apr 10, 2019, 07:09 PM
Lew JenniferChief Financial OfficerApr 08, 2019 Sale$4.0718,60175,775135,155Apr 10, 2019, 07:09 PM
van Elsas AndreaChief Scientific OfficerMar 19, 2019 Sale$3.966,08124,107239,557Mar 21, 2019, 05:35 PM
van Elsas AndreaChief Scientific OfficerFeb 26, 2019 Sale$4.256,84429,120245,638Feb 27, 2019, 07:07 PM
van Elsas AndreaChief Scientific OfficerDec 28, 2018 Sale$2.571,9074,901252,482Dec 31, 2018, 04:02 PM
Lew JenniferChief Financial OfficerDec 12, 2018 Sale$2.931,0353,035135,155Dec 14, 2018, 04:19 PM
Templeman BlaineChief Legal OfficerDec 12, 2018 Sale$2.931,2413,639129,878Dec 14, 2018, 04:18 PM
ISAACS STEPHEN TPresident and CEODec 12, 2018 Sale$2.935,82917,091327,024Dec 14, 2018, 04:17 PM
van Elsas AndreaChief Scientific OfficerDec 12, 2018 Sale$2.932,1716,365254,389Dec 14, 2018, 04:15 PM
Templeman BlaineChief Legal OfficerNov 20, 2018 Sale$2.918432,453131,119Nov 20, 2018, 07:58 PM
van Elsas AndreaChief Scientific OfficerSep 24, 2018 Sale$5.837,72645,022256,560Sep 25, 2018, 08:11 PM
Templeman BlaineChief Legal OfficerSep 24, 2018 Sale$5.8110,26259,613131,119Sep 25, 2018, 08:10 PM
Templeman BlaineExecutive VP, General CounselSep 13, 2018 Sale$6.506,05639,360141,381Sep 14, 2018, 07:29 PM
van Elsas AndreaChief Scientific OfficerSep 13, 2018 Sale$6.509,75463,394264,286Sep 14, 2018, 07:28 PM
Lew JenniferChief Financial OfficerSep 13, 2018 Sale$6.505,62336,546136,190Sep 14, 2018, 07:27 PM
Sacks NatalieChief Medical OfficerSep 13, 2018 Sale$6.503,02819,680173,720Sep 14, 2018, 07:25 PM
ISAACS STEPHEN TPresident and CEOSep 13, 2018 Sale$6.5024,143156,913332,853Sep 14, 2018, 07:24 PM
ISAACS STEPHEN TPresident and CEOSep 06, 2018 Option Exercise$1.0046,98746,987252,733Sep 06, 2018, 07:42 PM
ISAACS STEPHEN TPresident and CEOSep 05, 2018 Option Exercise$1.0015,58515,585221,331Sep 06, 2018, 07:42 PM
ISAACS STEPHEN TPresident and CEOSep 06, 2018 Sale$7.9246,987372,024205,746Sep 06, 2018, 07:42 PM
ISAACS STEPHEN TPresident and CEOSep 05, 2018 Sale$7.9015,585123,134205,746Sep 06, 2018, 07:42 PM
Sacks NatalieChief Medical OfficerSep 04, 2018 Sale$7.134,50432,09989,548Sep 06, 2018, 07:40 PM
van Elsas AndreaChief Scientific OfficerJul 17, 2018 Sale$6.9610,45472,803206,215Jul 19, 2018, 07:39 PM
ISAACS STEPHEN TPresident and CEOJun 01, 2018 Option Exercise$1.0040,00040,000245,746Jun 05, 2018, 08:58 PM
ISAACS STEPHEN TPresident and CEOJun 01, 2018 Sale$8.6840,000347,004205,746Jun 05, 2018, 08:58 PM
Templeman BlaineChief Legal OfficerMay 17, 2018 Sale$8.152,00016,30069,937May 21, 2018, 06:25 PM
ISAACS STEPHEN TPresident and CEOMay 09, 2018 Option Exercise$0.9740,00038,976245,746May 11, 2018, 05:00 PM
ISAACS STEPHEN TPresident and CEOMay 09, 2018 Sale$8.0140,000320,348205,746May 11, 2018, 05:00 PM
ISAACS STEPHEN TPresident and CEOApr 02, 2018 Option Exercise$0.8240,00032,800245,746Apr 04, 2018, 06:26 PM
ISAACS STEPHEN TPresident and CEOApr 02, 2018 Sale$8.9140,000356,400205,746Apr 04, 2018, 06:26 PM
ISAACS STEPHEN TPresident and CEOMar 09, 2018 Option Exercise$0.5046,41723,165252,163Mar 09, 2018, 07:40 PM
ISAACS STEPHEN TPresident and CEOMar 08, 2018 Option Exercise$0.4525,63411,535231,380Mar 09, 2018, 07:40 PM
ISAACS STEPHEN TPresident and CEOMar 09, 2018 Sale$8.7746,417407,268226,351Mar 09, 2018, 07:40 PM
ISAACS STEPHEN TPresident and CEOMar 08, 2018 Sale$7.9525,634203,790205,746Mar 09, 2018, 07:40 PM
van Elsas AndreaChief Scientific OfficerFeb 26, 2018 Sale$6.486,87444,522216,669Feb 27, 2018, 06:56 PM
SCHAFER GREGORY WChief Operating OfficerJan 25, 2018 Option Exercise$0.8260,00049,200250,745Jan 26, 2018, 07:15 PM
SCHAFER GREGORY WChief Operating OfficerJan 25, 2018 Option Exercise$0.013,31733254,062Jan 26, 2018, 07:15 PM
ISAACS STEPHEN TPresident and CEOJan 05, 2018 Option Exercise$0.457,9493,577213,695Jan 09, 2018, 05:48 PM
ISAACS STEPHEN TPresident and CEOJan 05, 2018 Sale$7.957,94963,195205,746Jan 09, 2018, 05:48 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 29, 2017 Option Exercise$1.4552,00075,400124,603Jan 03, 2018, 07:03 PM
SCHAFER GREGORY WChief Operating OfficerJan 02, 2018 Option Exercise$1.0420,00020,767210,745Jan 03, 2018, 06:59 PM
SCHAFER GREGORY WChief Operating OfficerDec 29, 2017 Option Exercise$0.8242,00034,440190,745Jan 03, 2018, 06:59 PM
SCHAFER GREGORY WChief Operating OfficerJan 02, 2018 Sale$7.6120,000152,142190,745Jan 03, 2018, 06:59 PM
Templeman BlaineExecutive VP, General CounselDec 18, 2017 Sale$8.252,88423,79369,937Dec 20, 2017, 06:52 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 15, 2017 Option Exercise$1.4564,10892,957137,826Dec 15, 2017, 08:02 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 15, 2017 Sale$8.1165,223529,18772,603Dec 15, 2017, 08:02 PM
van Elsas AndreaChief Scientific OfficerSep 13, 2017 Sale$10.994,92254,072202,581Dec 15, 2017, 07:58 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 01, 2017 Option Exercise$0.5210,0005,20083,718Dec 04, 2017, 07:59 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 01, 2017 Sale$9.4010,00093,99873,718Dec 04, 2017, 07:59 PM
Lew JenniferSr. Vice President of FinanceDec 01, 2017 Option Exercise$0.826,6005,41268,938Dec 04, 2017, 07:57 PM
Lew JenniferSr. Vice President of FinanceDec 01, 2017 Sale$9.466,60062,43362,338Dec 04, 2017, 07:57 PM
SCHAFER GREGORY WChief Operating OfficerDec 01, 2017 Option Exercise$1.0420,00020,767168,745Dec 04, 2017, 07:56 PM
SCHAFER GREGORY WChief Operating OfficerDec 01, 2017 Sale$9.3420,000186,882148,745Dec 04, 2017, 07:56 PM
ISAACS STEPHEN TPresident and CEODec 01, 2017 Option Exercise$0.4540,00018,000213,921Dec 04, 2017, 07:53 PM
ISAACS STEPHEN TPresident and CEODec 01, 2017 Sale$9.3840,000375,028173,921Dec 04, 2017, 07:53 PM
Templeman BlaineExecutive VP, General CounselNov 17, 2017 Sale$8.852432,15158,834Nov 17, 2017, 06:43 PM
Lew JenniferSr. Vice President of FinanceNov 15, 2017 Option Exercise$0.826,6005,41268,938Nov 17, 2017, 06:42 PM
Lew JenniferSr. Vice President of FinanceNov 15, 2017 Sale$8.956,60059,07062,338Nov 17, 2017, 06:42 PM
ISAACS STEPHEN TPresident and CEONov 13, 2017 Option Exercise$0.453,4001,530177,321Nov 14, 2017, 06:20 PM
ISAACS STEPHEN TPresident and CEONov 10, 2017 Option Exercise$0.4516,4007,380190,321Nov 14, 2017, 06:20 PM
ISAACS STEPHEN TPresident and CEONov 13, 2017 Sale$8.003,40027,215173,921Nov 14, 2017, 06:20 PM
ISAACS STEPHEN TPresident and CEONov 10, 2017 Sale$7.9616,400130,508173,921Nov 14, 2017, 06:20 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 13, 2017 Option Exercise$0.524,0622,11277,780Nov 14, 2017, 06:09 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 10, 2017 Option Exercise$0.521,81594475,533Nov 14, 2017, 06:09 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 13, 2017 Sale$8.004,06232,49673,718Nov 14, 2017, 06:09 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 10, 2017 Sale$8.011,81514,54473,718Nov 14, 2017, 06:09 PM
SCHAFER GREGORY WChief Operating OfficerNov 06, 2017 Option Exercise$1.0420,00020,767168,745Nov 08, 2017, 08:01 PM
SCHAFER GREGORY WChief Operating OfficerNov 06, 2017 Sale$7.9720,000159,312148,745Nov 08, 2017, 08:01 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 06, 2017 Option Exercise$0.524,1232,14477,841Nov 08, 2017, 07:59 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 06, 2017 Sale$8.044,12333,13273,718Nov 08, 2017, 07:59 PM
ISAACS STEPHEN TPresident and CEONov 07, 2017 Option Exercise$0.453,8001,710177,721Nov 08, 2017, 07:56 PM
ISAACS STEPHEN TPresident and CEONov 06, 2017 Option Exercise$0.4516,4007,380190,321Nov 08, 2017, 07:56 PM
ISAACS STEPHEN TPresident and CEONov 07, 2017 Sale$7.953,80030,223173,921Nov 08, 2017, 07:56 PM
ISAACS STEPHEN TPresident and CEONov 06, 2017 Sale$7.9816,400130,934173,921Nov 08, 2017, 07:56 PM
Brockstedt Dirk G.EVP of Research and Dev.Oct 02, 2017 Option Exercise$0.5210,0005,20083,718Oct 04, 2017, 08:31 PM
Brockstedt Dirk G.EVP of Research and Dev.Oct 02, 2017 Sale$10.5910,000105,87073,718Oct 04, 2017, 08:31 PM
SCHAFER GREGORY WChief Operating OfficerOct 02, 2017 Option Exercise$1.3620,00027,148168,745Oct 04, 2017, 08:26 PM
SCHAFER GREGORY WChief Operating OfficerOct 02, 2017 Sale$10.7520,000215,060148,745Oct 04, 2017, 08:26 PM
ISAACS STEPHEN TPresident and CEOOct 02, 2017 Option Exercise$0.4540,00018,000213,921Oct 04, 2017, 08:23 PM
ISAACS STEPHEN TPresident and CEOOct 02, 2017 Sale$10.7840,000431,032173,921Oct 04, 2017, 08:23 PM
Lew JenniferSr. Vice President of FinanceOct 02, 2017 Option Exercise$0.826,6005,41268,938Oct 04, 2017, 08:21 PM
Lew JenniferSr. Vice President of FinanceOct 02, 2017 Sale$10.616,60069,99562,338Oct 04, 2017, 08:21 PM
Templeman BlaineExecutive VP, General CounselSep 18, 2017 Sale$11.202,88432,30158,834Sep 20, 2017, 07:11 PM
ISAACS STEPHEN TPresident and CEOSep 13, 2017 Sale$10.9912,204134,071173,921Sep 14, 2017, 09:25 PM
SCHAFER GREGORY WChief Operating OfficerSep 13, 2017 Sale$10.994,85953,380148,745Sep 14, 2017, 09:24 PM
Brockstedt Dirk G.EVP of Research and Dev.Sep 13, 2017 Sale$10.993,55739,07673,718Sep 14, 2017, 09:22 PM
Lew JenniferSr. Vice President of FinanceSep 13, 2017 Sale$10.993,55739,07662,338Sep 14, 2017, 09:21 PM
van Elsas AndreaChief Scientific OfficerSep 13, 2017 Sale$10.994,92254,072207,231Sep 14, 2017, 09:20 PM
Templeman BlaineExecutive VP, General CounselSep 13, 2017 Sale$10.993,55739,07661,718Sep 14, 2017, 09:19 PM
Sacks NatalieChief Medical OfficerSep 01, 2017 Sale$11.714,88557,19645,115Sep 06, 2017, 04:32 PM
SCHAFER GREGORY WChief Operating OfficerSep 01, 2017 Option Exercise$1.2420,00024,800140,979Sep 06, 2017, 04:30 PM
SCHAFER GREGORY WChief Operating OfficerSep 01, 2017 Sale$11.7020,000233,980120,979Sep 06, 2017, 04:30 PM
Lew JenniferSr. Vice President of FinanceSep 01, 2017 Option Exercise$0.826,6005,41249,195Sep 06, 2017, 04:29 PM
Lew JenniferSr. Vice President of FinanceSep 01, 2017 Sale$11.706,60077,24242,595Sep 06, 2017, 04:29 PM
ISAACS STEPHEN TPresident and CEOSep 01, 2017 Option Exercise$0.4540,00018,000144,025Sep 06, 2017, 04:28 PM
ISAACS STEPHEN TPresident and CEOSep 01, 2017 Sale$11.7140,000468,596104,025Sep 06, 2017, 04:28 PM
Brockstedt Dirk G.EVP of Research and Dev.Sep 01, 2017 Option Exercise$0.5210,0005,20059,300Sep 06, 2017, 04:27 PM
Brockstedt Dirk G.EVP of Research and Dev.Sep 01, 2017 Sale$11.6910,000116,94849,300Sep 06, 2017, 04:27 PM
Dubensky Thomas W.Chief Scientific OfficerAug 10, 2017 Option Exercise$1.0040,91240,91280,812Aug 11, 2017, 08:03 PM
Dubensky Thomas W.Chief Scientific OfficerAug 11, 2017 Option Exercise$1.009,0889,08848,988Aug 11, 2017, 08:03 PM
Dubensky Thomas W.Chief Scientific OfficerAug 11, 2017 Sale$11.179,088101,53839,900Aug 11, 2017, 08:03 PM
Dubensky Thomas W.Chief Scientific OfficerAug 10, 2017 Sale$11.4340,912467,66539,900Aug 11, 2017, 08:03 PM
ISAACS STEPHEN TPresident and CEOAug 07, 2017 Option Exercise$0.4540,00018,000144,025Aug 09, 2017, 07:46 PM
ISAACS STEPHEN TPresident and CEOAug 07, 2017 Sale$12.1940,000487,564104,025Aug 09, 2017, 07:46 PM
SCHAFER GREGORY WChief Operating OfficerAug 07, 2017 Option Exercise$1.2225,81131,616146,790Aug 09, 2017, 07:45 PM
SCHAFER GREGORY WChief Operating OfficerAug 08, 2017 Option Exercise$1.2714,18918,004135,168Aug 09, 2017, 07:45 PM
SCHAFER GREGORY WChief Operating OfficerAug 08, 2017 Sale$12.1614,189172,550120,979Aug 09, 2017, 07:45 PM
SCHAFER GREGORY WChief Operating OfficerAug 07, 2017 Sale$12.1725,811314,233120,979Aug 09, 2017, 07:45 PM
Brockstedt Dirk G.EVP of Research and Dev.Aug 07, 2017 Option Exercise$0.5210,0005,20059,300Aug 09, 2017, 07:44 PM
Brockstedt Dirk G.EVP of Research and Dev.Aug 07, 2017 Sale$12.1810,000121,79549,300Aug 09, 2017, 07:44 PM
Lew JenniferSr. Vice President of FinanceAug 07, 2017 Option Exercise$0.826,6005,41249,195Aug 09, 2017, 07:41 PM
Lew JenniferSr. Vice President of FinanceAug 07, 2017 Sale$12.176,60080,29042,595Aug 09, 2017, 07:41 PM
Lew JenniferSr. Vice President of FinanceJul 03, 2017 Option Exercise$0.8212,0009,84054,595Jul 06, 2017, 07:13 PM
Lew JenniferSr. Vice President of FinanceJul 03, 2017 Sale$11.1412,000133,63242,595Jul 06, 2017, 07:13 PM
ISAACS STEPHEN TPresident and CEOJul 03, 2017 Option Exercise$0.5040,00019,965144,025Jul 06, 2017, 07:12 PM
ISAACS STEPHEN TPresident and CEOJul 05, 2017 Sale$11.011,34114,763104,025Jul 06, 2017, 07:12 PM
ISAACS STEPHEN TPresident and CEOJul 03, 2017 Sale$11.0638,659427,634105,366Jul 06, 2017, 07:12 PM
Brockstedt Dirk G.EVP of Research and Dev.Jul 03, 2017 Option Exercise$0.4810,0004,82659,300Jul 06, 2017, 07:11 PM
Brockstedt Dirk G.EVP of Research and Dev.Jul 03, 2017 Sale$11.0210,000110,16749,300Jul 06, 2017, 07:11 PM
Dubensky Thomas W.Chief Scientific OfficerJul 05, 2017 Option Exercise$0.5233,68817,51873,588Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 03, 2017 Option Exercise$0.5211,8006,13651,700Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 06, 2017 Option Exercise$0.524,5122,34644,412Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 05, 2017 Sale$11.4633,688385,93639,900Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 03, 2017 Sale$11.0211,800130,02839,900Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 06, 2017 Sale$11.234,51250,67339,900Jul 06, 2017, 07:10 PM
Lew JenniferSr. Vice President of FinanceJun 28, 2017 Option Exercise$0.8212,0009,84054,595Jun 30, 2017, 06:03 PM
Lew JenniferSr. Vice President of FinanceJun 28, 2017 Sale$11.1912,000134,23642,595Jun 30, 2017, 06:03 PM
SCHAFER GREGORY WChief Operating OfficerJun 28, 2017 Option Exercise$1.4540,00058,000160,979Jun 30, 2017, 06:01 PM
SCHAFER GREGORY WChief Operating OfficerJun 28, 2017 Sale$11.2640,000450,568120,979Jun 30, 2017, 06:01 PM
ISAACS STEPHEN TPresident and CEOJun 19, 2017 Option Exercise$0.5240,00020,800144,025Jun 21, 2017, 06:56 PM
ISAACS STEPHEN TPresident and CEOJun 19, 2017 Sale$10.5040,000420,164104,025Jun 21, 2017, 06:56 PM
Dubensky Thomas W.Chief Scientific OfficerJun 05, 2017 Option Exercise$0.5217,5779,14057,477Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 02, 2017 Option Exercise$0.5248,75325,35288,653Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 01, 2017 Option Exercise$0.5277,97140,545117,871Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 02, 2017 Sale$10.1048,753492,28339,900Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 01, 2017 Sale$10.0077,971779,86639,900Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 05, 2017 Sale$9.9917,577175,62839,900Jun 05, 2017, 07:25 PM
Brockstedt Dirk G.EVP of Research and Dev.Jun 01, 2017 Option Exercise$0.528,0004,16057,300Jun 05, 2017, 07:22 PM
Brockstedt Dirk G.EVP of Research and Dev.Jun 01, 2017 Sale$10.008,00080,02049,300Jun 05, 2017, 07:22 PM
Brockstedt Dirk G.EVP of Research and Dev.May 17, 2017 Sale$9.651,0119,75649,300May 18, 2017, 08:33 PM
Templeman BlaineExecutive VP, General CounselMay 17, 2017 Sale$9.651,64815,90337,300May 18, 2017, 08:30 PM
ISAACS STEPHEN TPresident and CEOMay 16, 2017 Option Exercise$0.5216,6738,670120,698May 17, 2017, 05:55 PM
ISAACS STEPHEN TPresident and CEOMay 15, 2017 Option Exercise$0.5210,6005,512114,625May 17, 2017, 05:55 PM
ISAACS STEPHEN TPresident and CEOMay 16, 2017 Sale$10.0016,673166,797104,025May 17, 2017, 05:55 PM
ISAACS STEPHEN TPresident and CEOMay 15, 2017 Sale$10.0110,600106,154104,025May 17, 2017, 05:55 PM
Brockstedt Dirk G.EVP of Research and Dev.May 11, 2017 Option Exercise$0.528,0004,16057,300May 15, 2017, 06:57 PM
Brockstedt Dirk G.EVP of Research and Dev.May 11, 2017 Sale$9.728,00077,72549,300May 15, 2017, 06:57 PM
Dubensky Thomas W.Chief Scientific OfficerMay 12, 2017 Option Exercise$0.524,2992,23544,199May 15, 2017, 06:56 PM
Dubensky Thomas W.Chief Scientific OfficerMay 11, 2017 Option Exercise$0.521,40072841,300May 15, 2017, 06:56 PM
Dubensky Thomas W.Chief Scientific OfficerMay 12, 2017 Sale$9.924,29942,65839,900May 15, 2017, 06:56 PM
Dubensky Thomas W.Chief Scientific OfficerMay 11, 2017 Sale$9.911,40013,87039,900May 15, 2017, 06:56 PM
Brockstedt Dirk G.EVP of Research and Dev.Apr 03, 2017 Option Exercise$0.458,0003,60057,300Apr 04, 2017, 08:18 PM
Brockstedt Dirk G.EVP of Research and Dev.Apr 03, 2017 Sale$10.718,00085,64549,300Apr 04, 2017, 08:18 PM
ISAACS STEPHEN TPresident and CEOApr 03, 2017 Option Exercise$0.5227,27314,182129,473Apr 04, 2017, 08:17 PM
ISAACS STEPHEN TPresident and CEOApr 03, 2017 Sale$10.2827,273280,429102,200Apr 04, 2017, 08:17 PM
ISAACS STEPHEN TPresident and CEOMar 13, 2017 Option Exercise$0.5227,27314,182129,473Mar 14, 2017, 08:02 PM
ISAACS STEPHEN TPresident and CEOMar 13, 2017 Sale$11.3527,273309,434102,200Mar 14, 2017, 08:02 PM
Brockstedt Dirk G.EVP of Research and Dev.Mar 09, 2017 Option Exercise$0.458,0003,60057,300Mar 10, 2017, 08:05 PM
Brockstedt Dirk G.EVP of Research and Dev.Mar 09, 2017 Sale$11.008,00088,00149,300Mar 10, 2017, 08:05 PM
Dubensky Thomas W.Chief Scientific OfficerMar 09, 2017 Option Exercise$0.7825,00019,44664,900Mar 10, 2017, 08:04 PM
Dubensky Thomas W.Chief Scientific OfficerMar 09, 2017 Sale$10.9625,000274,07839,900Mar 10, 2017, 08:04 PM
Brockstedt Dirk G.EVP of Research and Dev.Jan 17, 2017 Option Exercise$0.458,0003,60057,300Jan 19, 2017, 06:52 PM
Brockstedt Dirk G.EVP of Research and Dev.Jan 17, 2017 Sale$11.868,00094,85849,300Jan 19, 2017, 06:52 PM
Templeman BlaineExecutive VP, General CounselJan 11, 2017 Sale$11.953,78545,23137,300Jan 13, 2017, 04:33 PM
Dubensky Thomas W.Chief Scientific OfficerJan 03, 2017 Option Exercise$0.5225,00013,00064,900Jan 05, 2017, 05:15 PM
Dubensky Thomas W.Chief Scientific OfficerJan 03, 2017 Sale$11.1625,000278,99039,900Jan 05, 2017, 05:15 PM
ISAACS STEPHEN TPresident and CEOJan 03, 2017 Option Exercise$0.5227,27314,182129,473Jan 05, 2017, 05:14 PM
ISAACS STEPHEN TPresident and CEOJan 03, 2017 Sale$11.1227,273303,289102,200Jan 05, 2017, 05:14 PM
SCHAFER GREGORY WChief Operating OfficerDec 23, 2016 Option Exercise$0.8235,00028,700120,979Dec 27, 2016, 09:12 AM
ISAACS STEPHEN TPresident and CEODec 01, 2016 Option Exercise$0.5227,27314,182129,473Dec 05, 2016, 07:23 PM
ISAACS STEPHEN TPresident and CEODec 01, 2016 Sale$10.8227,273295,169102,300Dec 05, 2016, 07:23 PM
Dubensky Thomas W.Chief Scientific OfficerDec 01, 2016 Option Exercise$1.0425,00025,89364,900Dec 05, 2016, 07:21 PM
Dubensky Thomas W.Chief Scientific OfficerDec 01, 2016 Sale$10.9425,000273,50039,900Dec 05, 2016, 07:21 PM
Haghighat RossDirectorNov 14, 2016 Sale$15.507,088109,86481,880Nov 16, 2016, 09:19 PM
ISAACS STEPHEN TPresident and CEONov 14, 2016 Option Exercise$0.5227,27314,182129,473Nov 16, 2016, 05:06 PM
ISAACS STEPHEN TPresident and CEONov 14, 2016 Sale$15.2627,273416,050102,200Nov 16, 2016, 05:06 PM
Lew JenniferSr. Vice President of FinanceNov 10, 2016 Option Exercise$0.8210,9108,94653,505Nov 14, 2016, 07:02 PM
Lew JenniferSr. Vice President of FinanceNov 10, 2016 Sale$14.9510,910163,10442,595Nov 14, 2016, 07:02 PM
SCHAFER GREGORY WChief Operating OfficerNov 11, 2016 Option Exercise$1.4530,14443,709116,123Nov 14, 2016, 07:01 PM
SCHAFER GREGORY WChief Operating OfficerNov 10, 2016 Option Exercise$1.4549,85672,291135,835Nov 14, 2016, 07:01 PM
SCHAFER GREGORY WChief Operating OfficerNov 11, 2016 Sale$14.8630,144448,03385,979Nov 14, 2016, 07:01 PM
SCHAFER GREGORY WChief Operating OfficerNov 10, 2016 Sale$14.7449,856734,69885,979Nov 14, 2016, 07:01 PM
Dubensky Thomas W.Chief Scientific OfficerNov 10, 2016 Option Exercise$1.3025,00032,58864,900Nov 14, 2016, 07:00 PM
Dubensky Thomas W.Chief Scientific OfficerNov 10, 2016 Sale$14.7825,000369,40839,900Nov 14, 2016, 07:00 PM
ISAACS STEPHEN TPresident and CEOOct 03, 2016 Option Exercise$0.5227,27314,182129,473Oct 05, 2016, 05:22 PM
ISAACS STEPHEN TPresident and CEOOct 03, 2016 Sale$12.6727,273345,522102,200Oct 05, 2016, 05:22 PM
Dubensky Thomas W.Chief Scientific OfficerOct 03, 2016 Option Exercise$1.1025,00027,43764,900Oct 05, 2016, 05:18 PM
Dubensky Thomas W.Chief Scientific OfficerOct 03, 2016 Sale$12.6825,000316,90839,900Oct 05, 2016, 05:18 PM
Lew JenniferSr. Vice President of FinanceSep 19, 2016 Option Exercise$0.825,4554,47348,955Sep 21, 2016, 04:57 PM
Lew JenniferSr. Vice President of FinanceSep 19, 2016 Sale$14.956,36095,08242,595Sep 21, 2016, 04:57 PM
Dubensky Thomas W.Chief Scientific OfficerSep 01, 2016 Option Exercise$1.1325,00028,25925,000Sep 02, 2016, 04:24 PM
Dubensky Thomas W.Chief Scientific OfficerSep 01, 2016 Sale$14.0325,000350,7750Sep 02, 2016, 04:24 PM
Dubensky Thomas W.Chief Scientific OfficerAug 11, 2016 Option Exercise$0.9925,00024,62525,000Aug 12, 2016, 05:43 PM
Dubensky Thomas W.Chief Scientific OfficerAug 11, 2016 Sale$15.1825,000379,5000Aug 12, 2016, 05:43 PM
Dubensky Thomas W.Chief Scientific OfficerJul 05, 2016 Option Exercise$1.0425,00025,96325,000Jul 07, 2016, 06:38 PM
Dubensky Thomas W.Chief Scientific OfficerJul 05, 2016 Sale$11.6125,000290,2500Jul 07, 2016, 06:38 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.May 16, 2016 Sale$8.209057,42112,000May 18, 2016, 07:14 PM
SCHAFER GREGORY WChief Operating OfficerMay 16, 2016 Sale$8.209057,42149,279May 18, 2016, 07:13 PM
Dubensky Thomas W.Chief Scientific OfficerMay 16, 2016 Sale$8.209057,4210May 18, 2016, 07:11 PM
Morningside Venture (VI) Investments Ltd10% OwnerFeb 18, 2016 Option Exercise$0.10762,01476,09719,805,532Feb 22, 2016, 05:59 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Jan 11, 2016 Option Exercise$0.4922,00010,85633,044Jan 11, 2016, 08:35 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Jan 11, 2016 Sale$21.7722,000479,01514,406Jan 11, 2016, 08:35 PM
SCHAFER GREGORY WChief Operating OfficerJan 08, 2016 Option Exercise$1.0020,00020,00069,279Jan 11, 2016, 08:33 PM
SCHAFER GREGORY WChief Operating OfficerJan 08, 2016 Sale$23.5820,000471,60049,279Jan 11, 2016, 08:33 PM
Dubensky Thomas W.Chief Scientific OfficerJan 04, 2016 Option Exercise$4.6815,00070,15815,000Jan 06, 2016, 06:18 PM
Dubensky Thomas W.Chief Scientific OfficerJan 04, 2016 Sale$26.3715,000395,5313,771Jan 06, 2016, 06:18 PM
ISAACS STEPHEN TPresident and CEOJan 04, 2016 Option Exercise$0.5212,5006,50022,500Jan 06, 2016, 06:16 PM
ISAACS STEPHEN TPresident and CEOJan 05, 2016 Option Exercise$0.5212,5006,50022,500Jan 06, 2016, 06:16 PM
ISAACS STEPHEN TPresident and CEOJan 05, 2016 Sale$26.2612,500328,19610,906Jan 06, 2016, 06:16 PM
ISAACS STEPHEN TPresident and CEOJan 04, 2016 Sale$26.3712,500329,60310,300Jan 06, 2016, 06:16 PM
Lew JenniferSr. Vice President of FinanceJan 06, 2016 Option Exercise$0.825,2424,29811,442Jan 06, 2016, 06:13 PM
Lew JenniferSr. Vice President of FinanceJan 06, 2016 Sale$25.715,242134,7657,000Jan 06, 2016, 06:13 PM
ISAACS STEPHEN TPresident and CEODec 31, 2015 Option Exercise$0.4510,0004,50010,000Jan 04, 2016, 07:04 PM
Lew JenniferSr. Vice President of FinanceDec 29, 2015 Option Exercise$0.824,2003,4446,200Dec 29, 2015, 06:11 PM
SCHAFER GREGORY WChief Operating OfficerDec 24, 2015 Option Exercise$0.8215,00012,30049,279Dec 28, 2015, 07:22 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Dec 16, 2015 Option Exercise$1.4512,00017,40012,000Dec 17, 2015, 07:06 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Dec 10, 2015 Option Exercise$1.4525,00036,25025,000Dec 14, 2015, 06:42 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Dec 10, 2015 Sale$29.8225,000745,42319,265Dec 14, 2015, 06:42 PM
SCHAFER GREGORY WChief Operating OfficerDec 07, 2015 Option Exercise$1.4525,00036,25059,279Dec 07, 2015, 07:40 PM
SCHAFER GREGORY WChief Operating OfficerDec 07, 2015 Sale$29.7425,000743,57142,579Dec 07, 2015, 07:40 PM
Lew JenniferSr. Vice President of FinanceDec 03, 2015 Option Exercise$0.825,2424,2987,242Dec 07, 2015, 07:32 PM
Lew JenniferSr. Vice President of FinanceDec 03, 2015 Sale$29.855,242156,4862,100Dec 07, 2015, 07:32 PM
ISAACS STEPHEN TPresident and CEODec 01, 2015 Option Exercise$0.5225,00013,00025,000Dec 02, 2015, 06:26 PM
ISAACS STEPHEN TPresident and CEODec 01, 2015 Sale$29.1125,000727,6642,200Dec 02, 2015, 06:26 PM
Dubensky Thomas W.Chief Scientific OfficerDec 01, 2015 Option Exercise$2.1530,00064,37330,000Dec 02, 2015, 06:24 PM
Dubensky Thomas W.Chief Scientific OfficerDec 01, 2015 Sale$29.2730,000878,1049,626Dec 02, 2015, 06:24 PM
Greenman William MarinerDirectorNov 30, 2015 Sale$30.653,00091,9500Dec 02, 2015, 06:21 PM
Lew JenniferSr. Vice President of FinanceNov 18, 2015 Option Exercise$0.825,2424,2988,712Nov 18, 2015, 08:30 PM
Lew JenniferSr. Vice President of FinanceNov 18, 2015 Sale$28.526,712191,4263,470Nov 18, 2015, 08:30 PM
ISAACS STEPHEN TPresident and CEONov 16, 2015 Option Exercise$0.5225,00013,00025,000Nov 18, 2015, 08:27 PM
ISAACS STEPHEN TPresident and CEONov 16, 2015 Sale$27.5425,000688,4902,700Nov 18, 2015, 08:27 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Nov 17, 2015 Option Exercise$0.6919,04713,22019,047Nov 18, 2015, 08:24 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Nov 16, 2015 Option Exercise$0.455,9532,6797,423Nov 18, 2015, 08:24 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Nov 17, 2015 Sale$28.6519,047545,73416,947Nov 18, 2015, 08:24 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Nov 16, 2015 Sale$27.527,423204,2941,470Nov 18, 2015, 08:24 PM
SCHAFER GREGORY WChief Operating OfficerNov 16, 2015 Option Exercise$1.459,82214,24245,571Nov 18, 2015, 08:21 PM
SCHAFER GREGORY WChief Operating OfficerNov 17, 2015 Option Exercise$1.4515,17822,00849,457Nov 18, 2015, 08:21 PM
SCHAFER GREGORY WChief Operating OfficerNov 16, 2015 Sale$27.5611,292311,16836,349Nov 18, 2015, 08:21 PM
SCHAFER GREGORY WChief Operating OfficerNov 17, 2015 Sale$28.6015,178434,07246,849Nov 18, 2015, 08:21 PM
Dubensky Thomas W.Chief Scientific OfficerNov 17, 2015 Option Exercise$1.4520,51929,75320,519Nov 18, 2015, 08:11 PM
Dubensky Thomas W.Chief Scientific OfficerNov 16, 2015 Option Exercise$1.459,48113,74710,951Nov 18, 2015, 08:11 PM
Dubensky Thomas W.Chief Scientific OfficerNov 17, 2015 Sale$28.6520,519587,82218,520Nov 18, 2015, 08:11 PM
Dubensky Thomas W.Chief Scientific OfficerNov 16, 2015 Sale$27.5510,951301,7332,170Nov 18, 2015, 08:11 PM
ISAACS STEPHEN TPresident and CEOJul 24, 2015 Option Exercise$0.0511,916609154,687Jul 27, 2015, 06:51 PM
Rogers John E. and Lois A.10% OwnerApr 20, 2015 Buy$17.007,500127,50033,649Apr 22, 2015, 05:50 PM
Rogers John E. and Lois A.10% OwnerApr 20, 2015 Buy$17.0010,000170,00036,149Apr 22, 2015, 05:50 PM
Rogers John E. and Lois A.10% OwnerApr 20, 2015 Buy$17.00147,0582,499,9865,991,759Apr 22, 2015, 05:49 PM
Morningside Venture (VI) Investments Ltd10% OwnerApr 20, 2015 Buy$17.00441,1767,499,99219,043,518Apr 22, 2015, 05:46 PM
OBrien Stephanie MonaghanDirectorApr 20, 2015 Buy$17.001,70028,9001,700Apr 22, 2015, 05:45 PM
OBrien Stephanie MonaghanDirectorApr 20, 2015 Buy$17.001,70028,9001,700Apr 22, 2015, 05:45 PM
Greenman William MarinerDirectorApr 20, 2015 Buy$17.003,00051,0003,000Apr 22, 2015, 05:43 PM
Lew JenniferSr. Vice President of FinanceApr 20, 2015 Buy$17.002,00034,0002,000Apr 22, 2015, 05:41 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
King Andrew JamesChief Scientific Officer08/01/202345,586
Greenman William MarinerDirector05/30/202326,911
DOBMEIER ERICPresident, CEO04/24/202310,500
DOBMEIER ERICPresident, CEO04/24/2023540,239
Jerel DavisDirector04/17/20236,138,223
King Andrew JamesChief Scientific Officer04/03/2023875
King Andrew JamesChief Scientific Officer04/03/2023116,718
Krishnan MaheshDirector04/04/202321,261
Jerel DavisDirector03/01/20239,100,000
BJERKHOLT ERICChief Financial Officer02/10/202320,352
DOBMEIER ERICPresident, CEO02/10/2023192,292
Frohlich TomChief Operating Officer02/10/202387,869
King Andrew JamesChief Scientific Officer02/10/202356,806
Frohlich TomChief Operating Officer01/31/2023112,700
BJERKHOLT ERICChief Financial Officer01/31/202371,357
King Andrew JamesChief Scientific Officer01/31/202380,069
DOBMEIER ERICPresident, CEO01/30/202310,500
DOBMEIER ERICPresident, CEO01/31/2023189,757
DOBMEIER ERICPresident, CEO01/30/2023613,613
King Andrew JamesChief Scientific Officer01/03/20232,625
King Andrew JamesChief Scientific Officer01/03/2023258,183
Frohlich TomChief Operating Officer12/13/20224,200
Frohlich TomChief Operating Officer12/13/2022250,005
DOBMEIER ERICPresident, CEO12/14/202210,500
DOBMEIER ERICPresident, CEO12/01/202225,200
DOBMEIER ERICPresident, CEO12/01/2022669,351
BJERKHOLT ERICChief Financial Officer12/01/2022128,602
Frohlich TomChief Operating Officer11/07/20224,200
Frohlich TomChief Operating Officer11/07/2022221,642
Frohlich TomChief Operating Officer10/06/2022144,933
King Andrew JamesChief Scientific Officer10/06/202270,044
Thomas DolcaDirector09/02/2022212,194
King Andrew JamesChief Scientific Officer08/04/20221,750
King Andrew JamesChief Scientific Officer08/04/2022100,000
King Andrew JamesChief Scientific Officer07/11/20221,750
King Andrew JamesChief Scientific Officer07/11/202290,468
AKKARAJU SRINIVASDirector05/27/20227,980,000
DOBMEIER ERICPresident, CEO05/25/202265,148
King Andrew JamesChief Scientific Officer04/11/20221,750
King Andrew JamesChief Scientific Officer04/11/202276,812
King Andrew JamesChief Scientific Officer02/18/202232,500
BJERKHOLT ERICChief Financial Officer02/11/202211,403
King Andrew JamesChief Scientific Officer02/11/202231,827
Glicklich AlanChief Medical Officer02/11/202230,464
Frohlich TomChief Operating Officer02/11/202247,587
King Andrew JamesChief Scientific Officer02/10/2022875
King Andrew JamesChief Scientific Officer02/10/202233,275
Versant Venture Capital VII, L.P.10% Owner01/03/20226,400,080
Versant Venture Capital VII, L.P.10% Owner01/03/20229,600,120
Jerel DavisDirector01/03/202216,000,200
DOBMEIER ERICPresident, CEO12/23/202114,000
BJERKHOLT ERICChief Financial Officer12/01/202192,097
AKKARAJU SRINIVASDirector11/15/202117,010,000
Frohlich TomChief Operating Officer11/10/202196,440
King Andrew JamesChief Scientific Officer11/09/2021875
King Andrew JamesChief Scientific Officer11/09/202167,660
Frohlich TomChief Operating Officer11/05/20216,300
Frohlich TomChief Operating Officer11/05/2021280,000
Frohlich TomChief Operating Officer11/08/2021208,938
Greenman William MarinerDirector10/21/20214,324
Frohlich TomChief Operating Officer10/06/202191,021
King Andrew JamesChief Scientific Officer10/06/202143,995
Glicklich AlanChief Medical Officer10/06/202130,785
Frohlich TomChief Operating Officer09/24/20218,400
Frohlich TomChief Operating Officer09/24/2021260,000
DOBMEIER ERICPresident, CEO09/20/202124,000
Jerel DavisDirector08/27/202111,900,000
Versant Venture Capital VII, L.P.10% Owner08/27/20214,760,000
Versant Venture Capital VII, L.P.10% Owner08/27/20217,140,000
AKKARAJU SRINIVASDirector08/18/20212,497,830
DOBMEIER ERICPresident, CEO08/19/202136,000
DOBMEIER ERICPresident, CEO08/18/202182,163
Glicklich AlanChief Medical Officer06/16/20218,400
Glicklich AlanChief Medical Officer06/16/2021326,968
DOBMEIER ERICPresident, CEO06/14/20217,000
DOBMEIER ERICPresident, CEO12/21/20207,000
DOBMEIER ERICPresident, CEO12/09/202026,150
DOBMEIER ERICPresident, CEO12/08/202026,483
DOBMEIER ERICPresident, CEO11/23/202012,699
DOBMEIER ERICPresident, CEO11/20/20207,817
DOBMEIER ERICPresident, CEO11/19/20206,750
DOBMEIER ERICPresident, CEO11/11/202034,375
DOBMEIER ERICPresident, CEO11/10/202027,720
ISAACS STEPHEN TPresident and CEO09/15/202077,691
Templeman BlaineChief Legal Officer09/15/202029,585
Ferber CelesteSVP, GC and Secretary09/15/20205,731
Nuyten Dimitry SAChief Medical Officer08/07/20209,036
Templeman BlaineChief Legal Officer08/07/202020,308
Ferber CelesteSVP, GC and Secretary08/07/202020,308
Greenman William MarinerDirector03/18/20208,926
ISAACS STEPHEN TPresident and CEO03/18/20209,728
van Elsas AndreaChief Scientific Officer02/25/202023,954
van Elsas AndreaChief Scientific Officer01/03/202087,108
Templeman BlaineChief Legal Officer12/12/20191,470
Ferber CelesteSVP, GC and Secretary12/12/2019475
van Elsas AndreaChief Scientific Officer12/12/20192,550
ISAACS STEPHEN TPresident and CEO12/12/20196,860
Haghighat RossDirector09/16/201935,527
Ferber CelesteSVP, GC and Secretary09/13/20193,257
ISAACS STEPHEN TPresident and CEO09/13/201940,608
van Elsas AndreaChief Scientific Officer09/13/201924,279
Templeman BlaineChief Legal Officer09/13/201916,817
Ferber CelesteSVP, GC and Secretary05/20/20196,413
Lew JenniferChief Financial Officer05/01/201923,306
Lew JenniferChief Financial Officer05/01/201978,136
Lew JenniferChief Financial Officer04/08/201923,305
Lew JenniferChief Financial Officer04/08/201975,775
van Elsas AndreaChief Scientific Officer03/19/201924,107
van Elsas AndreaChief Scientific Officer02/26/201929,120
van Elsas AndreaChief Scientific Officer12/28/20184,901
Lew JenniferChief Financial Officer12/12/20183,035
Templeman BlaineChief Legal Officer12/12/20183,639
ISAACS STEPHEN TPresident and CEO12/12/201817,091
van Elsas AndreaChief Scientific Officer12/12/20186,365
Templeman BlaineChief Legal Officer11/20/20182,453
van Elsas AndreaChief Scientific Officer09/24/201845,022
Templeman BlaineChief Legal Officer09/24/201859,613
Templeman BlaineExecutive VP, General Counsel09/13/201839,360
van Elsas AndreaChief Scientific Officer09/13/201863,394
Lew JenniferChief Financial Officer09/13/201836,546
Sacks NatalieChief Medical Officer09/13/201819,680
ISAACS STEPHEN TPresident and CEO09/13/2018156,913
ISAACS STEPHEN TPresident and CEO09/06/201846,987
ISAACS STEPHEN TPresident and CEO09/05/201815,585
ISAACS STEPHEN TPresident and CEO09/06/2018372,024
ISAACS STEPHEN TPresident and CEO09/05/2018123,134
Sacks NatalieChief Medical Officer09/04/201832,099
van Elsas AndreaChief Scientific Officer07/17/201872,803
ISAACS STEPHEN TPresident and CEO06/01/201840,000
ISAACS STEPHEN TPresident and CEO06/01/2018347,004
Templeman BlaineChief Legal Officer05/17/201816,300
ISAACS STEPHEN TPresident and CEO05/09/201838,976
ISAACS STEPHEN TPresident and CEO05/09/2018320,348
ISAACS STEPHEN TPresident and CEO04/02/201832,800
ISAACS STEPHEN TPresident and CEO04/02/2018356,400
ISAACS STEPHEN TPresident and CEO03/09/201823,165
ISAACS STEPHEN TPresident and CEO03/08/201811,535
ISAACS STEPHEN TPresident and CEO03/09/2018407,268
ISAACS STEPHEN TPresident and CEO03/08/2018203,790
van Elsas AndreaChief Scientific Officer02/26/201844,522
SCHAFER GREGORY WChief Operating Officer01/25/201849,200
SCHAFER GREGORY WChief Operating Officer01/25/201833
ISAACS STEPHEN TPresident and CEO01/05/20183,577
ISAACS STEPHEN TPresident and CEO01/05/201863,195
Brockstedt Dirk G.EVP of Research and Dev.12/29/201775,400
SCHAFER GREGORY WChief Operating Officer01/02/201820,767
SCHAFER GREGORY WChief Operating Officer12/29/201734,440
SCHAFER GREGORY WChief Operating Officer01/02/2018152,142
Templeman BlaineExecutive VP, General Counsel12/18/201723,793
Brockstedt Dirk G.EVP of Research and Dev.12/15/201792,957
Brockstedt Dirk G.EVP of Research and Dev.12/15/2017529,187
van Elsas AndreaChief Scientific Officer09/13/201754,072
Brockstedt Dirk G.EVP of Research and Dev.12/01/20175,200
Brockstedt Dirk G.EVP of Research and Dev.12/01/201793,998
Lew JenniferSr. Vice President of Finance12/01/20175,412
Lew JenniferSr. Vice President of Finance12/01/201762,433
SCHAFER GREGORY WChief Operating Officer12/01/201720,767
SCHAFER GREGORY WChief Operating Officer12/01/2017186,882
ISAACS STEPHEN TPresident and CEO12/01/201718,000
ISAACS STEPHEN TPresident and CEO12/01/2017375,028
Templeman BlaineExecutive VP, General Counsel11/17/20172,151
Lew JenniferSr. Vice President of Finance11/15/20175,412
Lew JenniferSr. Vice President of Finance11/15/201759,070
ISAACS STEPHEN TPresident and CEO11/13/20171,530
ISAACS STEPHEN TPresident and CEO11/10/20177,380
ISAACS STEPHEN TPresident and CEO11/13/201727,215
ISAACS STEPHEN TPresident and CEO11/10/2017130,508
Brockstedt Dirk G.EVP of Research and Dev.11/13/20172,112
Brockstedt Dirk G.EVP of Research and Dev.11/10/2017944
Brockstedt Dirk G.EVP of Research and Dev.11/13/201732,496
Brockstedt Dirk G.EVP of Research and Dev.11/10/201714,544
SCHAFER GREGORY WChief Operating Officer11/06/201720,767
SCHAFER GREGORY WChief Operating Officer11/06/2017159,312
Brockstedt Dirk G.EVP of Research and Dev.11/06/20172,144
Brockstedt Dirk G.EVP of Research and Dev.11/06/201733,132
ISAACS STEPHEN TPresident and CEO11/07/20171,710
ISAACS STEPHEN TPresident and CEO11/06/20177,380
ISAACS STEPHEN TPresident and CEO11/07/201730,223
ISAACS STEPHEN TPresident and CEO11/06/2017130,934
Brockstedt Dirk G.EVP of Research and Dev.10/02/20175,200
Brockstedt Dirk G.EVP of Research and Dev.10/02/2017105,870
SCHAFER GREGORY WChief Operating Officer10/02/201727,148
SCHAFER GREGORY WChief Operating Officer10/02/2017215,060
ISAACS STEPHEN TPresident and CEO10/02/201718,000
ISAACS STEPHEN TPresident and CEO10/02/2017431,032
Lew JenniferSr. Vice President of Finance10/02/20175,412
Lew JenniferSr. Vice President of Finance10/02/201769,995
Templeman BlaineExecutive VP, General Counsel09/18/201732,301
ISAACS STEPHEN TPresident and CEO09/13/2017134,071
SCHAFER GREGORY WChief Operating Officer09/13/201753,380
Brockstedt Dirk G.EVP of Research and Dev.09/13/201739,076
Lew JenniferSr. Vice President of Finance09/13/201739,076
van Elsas AndreaChief Scientific Officer09/13/201754,072
Templeman BlaineExecutive VP, General Counsel09/13/201739,076
Sacks NatalieChief Medical Officer09/01/201757,196
SCHAFER GREGORY WChief Operating Officer09/01/201724,800
SCHAFER GREGORY WChief Operating Officer09/01/2017233,980
Lew JenniferSr. Vice President of Finance09/01/20175,412
Lew JenniferSr. Vice President of Finance09/01/201777,242
ISAACS STEPHEN TPresident and CEO09/01/201718,000
ISAACS STEPHEN TPresident and CEO09/01/2017468,596
Brockstedt Dirk G.EVP of Research and Dev.09/01/20175,200
Brockstedt Dirk G.EVP of Research and Dev.09/01/2017116,948
Dubensky Thomas W.Chief Scientific Officer08/10/201740,912
Dubensky Thomas W.Chief Scientific Officer08/11/20179,088
Dubensky Thomas W.Chief Scientific Officer08/11/2017101,538
Dubensky Thomas W.Chief Scientific Officer08/10/2017467,665
ISAACS STEPHEN TPresident and CEO08/07/201718,000
ISAACS STEPHEN TPresident and CEO08/07/2017487,564
SCHAFER GREGORY WChief Operating Officer08/07/201731,616
SCHAFER GREGORY WChief Operating Officer08/08/201718,004
SCHAFER GREGORY WChief Operating Officer08/08/2017172,550
SCHAFER GREGORY WChief Operating Officer08/07/2017314,233
Brockstedt Dirk G.EVP of Research and Dev.08/07/20175,200
Brockstedt Dirk G.EVP of Research and Dev.08/07/2017121,795
Lew JenniferSr. Vice President of Finance08/07/20175,412
Lew JenniferSr. Vice President of Finance08/07/201780,290
Lew JenniferSr. Vice President of Finance07/03/20179,840
Lew JenniferSr. Vice President of Finance07/03/2017133,632
ISAACS STEPHEN TPresident and CEO07/03/201719,965
ISAACS STEPHEN TPresident and CEO07/05/201714,763
ISAACS STEPHEN TPresident and CEO07/03/2017427,634
Brockstedt Dirk G.EVP of Research and Dev.07/03/20174,826
Brockstedt Dirk G.EVP of Research and Dev.07/03/2017110,167
Dubensky Thomas W.Chief Scientific Officer07/05/201717,518
Dubensky Thomas W.Chief Scientific Officer07/03/20176,136
Dubensky Thomas W.Chief Scientific Officer07/06/20172,346
Dubensky Thomas W.Chief Scientific Officer07/05/2017385,936
Dubensky Thomas W.Chief Scientific Officer07/03/2017130,028
Dubensky Thomas W.Chief Scientific Officer07/06/201750,673
Lew JenniferSr. Vice President of Finance06/28/20179,840
Lew JenniferSr. Vice President of Finance06/28/2017134,236
SCHAFER GREGORY WChief Operating Officer06/28/201758,000
SCHAFER GREGORY WChief Operating Officer06/28/2017450,568
ISAACS STEPHEN TPresident and CEO06/19/201720,800
ISAACS STEPHEN TPresident and CEO06/19/2017420,164
Dubensky Thomas W.Chief Scientific Officer06/05/20179,140
Dubensky Thomas W.Chief Scientific Officer06/02/201725,352
Dubensky Thomas W.Chief Scientific Officer06/01/201740,545
Dubensky Thomas W.Chief Scientific Officer06/02/2017492,283
Dubensky Thomas W.Chief Scientific Officer06/01/2017779,866
Dubensky Thomas W.Chief Scientific Officer06/05/2017175,628
Brockstedt Dirk G.EVP of Research and Dev.06/01/20174,160
Brockstedt Dirk G.EVP of Research and Dev.06/01/201780,020
Brockstedt Dirk G.EVP of Research and Dev.05/17/20179,756
Templeman BlaineExecutive VP, General Counsel05/17/201715,903
ISAACS STEPHEN TPresident and CEO05/16/20178,670
ISAACS STEPHEN TPresident and CEO05/15/20175,512
ISAACS STEPHEN TPresident and CEO05/16/2017166,797
ISAACS STEPHEN TPresident and CEO05/15/2017106,154
Brockstedt Dirk G.EVP of Research and Dev.05/11/20174,160
Brockstedt Dirk G.EVP of Research and Dev.05/11/201777,725
Dubensky Thomas W.Chief Scientific Officer05/12/20172,235
Dubensky Thomas W.Chief Scientific Officer05/11/2017728
Dubensky Thomas W.Chief Scientific Officer05/12/201742,658
Dubensky Thomas W.Chief Scientific Officer05/11/201713,870
Brockstedt Dirk G.EVP of Research and Dev.04/03/20173,600
Brockstedt Dirk G.EVP of Research and Dev.04/03/201785,645
ISAACS STEPHEN TPresident and CEO04/03/201714,182
ISAACS STEPHEN TPresident and CEO04/03/2017280,429
ISAACS STEPHEN TPresident and CEO03/13/201714,182
ISAACS STEPHEN TPresident and CEO03/13/2017309,434
Brockstedt Dirk G.EVP of Research and Dev.03/09/20173,600
Brockstedt Dirk G.EVP of Research and Dev.03/09/201788,001
Dubensky Thomas W.Chief Scientific Officer03/09/201719,446
Dubensky Thomas W.Chief Scientific Officer03/09/2017274,078
Brockstedt Dirk G.EVP of Research and Dev.01/17/20173,600
Brockstedt Dirk G.EVP of Research and Dev.01/17/201794,858
Templeman BlaineExecutive VP, General Counsel01/11/201745,231
Dubensky Thomas W.Chief Scientific Officer01/03/201713,000
Dubensky Thomas W.Chief Scientific Officer01/03/2017278,990
ISAACS STEPHEN TPresident and CEO01/03/201714,182
ISAACS STEPHEN TPresident and CEO01/03/2017303,289
SCHAFER GREGORY WChief Operating Officer12/23/201628,700
ISAACS STEPHEN TPresident and CEO12/01/201614,182
ISAACS STEPHEN TPresident and CEO12/01/2016295,169
Dubensky Thomas W.Chief Scientific Officer12/01/201625,893
Dubensky Thomas W.Chief Scientific Officer12/01/2016273,500
Haghighat RossDirector11/14/2016109,864
ISAACS STEPHEN TPresident and CEO11/14/201614,182
ISAACS STEPHEN TPresident and CEO11/14/2016416,050
Lew JenniferSr. Vice President of Finance11/10/20168,946
Lew JenniferSr. Vice President of Finance11/10/2016163,104
SCHAFER GREGORY WChief Operating Officer11/11/201643,709
SCHAFER GREGORY WChief Operating Officer11/10/201672,291
SCHAFER GREGORY WChief Operating Officer11/11/2016448,033
SCHAFER GREGORY WChief Operating Officer11/10/2016734,698
Dubensky Thomas W.Chief Scientific Officer11/10/201632,588
Dubensky Thomas W.Chief Scientific Officer11/10/2016369,408
ISAACS STEPHEN TPresident and CEO10/03/201614,182
ISAACS STEPHEN TPresident and CEO10/03/2016345,522
Dubensky Thomas W.Chief Scientific Officer10/03/201627,437
Dubensky Thomas W.Chief Scientific Officer10/03/2016316,908
Lew JenniferSr. Vice President of Finance09/19/20164,473
Lew JenniferSr. Vice President of Finance09/19/201695,082
Dubensky Thomas W.Chief Scientific Officer09/01/201628,259
Dubensky Thomas W.Chief Scientific Officer09/01/2016350,775
Dubensky Thomas W.Chief Scientific Officer08/11/201624,625
Dubensky Thomas W.Chief Scientific Officer08/11/2016379,500
Dubensky Thomas W.Chief Scientific Officer07/05/201625,963
Dubensky Thomas W.Chief Scientific Officer07/05/2016290,250
Brockstedt Dirk G.Sr. VP of Research and Dev.05/16/20167,421
SCHAFER GREGORY WChief Operating Officer05/16/20167,421
Dubensky Thomas W.Chief Scientific Officer05/16/20167,421
Morningside Venture (VI) Investments Ltd10% Owner02/18/201676,097
Brockstedt Dirk G.Sr. VP of Research and Dev.01/11/201610,856
Brockstedt Dirk G.Sr. VP of Research and Dev.01/11/2016479,015
SCHAFER GREGORY WChief Operating Officer01/08/201620,000
SCHAFER GREGORY WChief Operating Officer01/08/2016471,600
Dubensky Thomas W.Chief Scientific Officer01/04/201670,158
Dubensky Thomas W.Chief Scientific Officer01/04/2016395,531
ISAACS STEPHEN TPresident and CEO01/04/20166,500
ISAACS STEPHEN TPresident and CEO01/05/20166,500
ISAACS STEPHEN TPresident and CEO01/05/2016328,196
ISAACS STEPHEN TPresident and CEO01/04/2016329,603
Lew JenniferSr. Vice President of Finance01/06/20164,298
Lew JenniferSr. Vice President of Finance01/06/2016134,765
ISAACS STEPHEN TPresident and CEO12/31/20154,500
Lew JenniferSr. Vice President of Finance12/29/20153,444
SCHAFER GREGORY WChief Operating Officer12/24/201512,300
Brockstedt Dirk G.Sr. VP of Research and Dev.12/16/201517,400
Brockstedt Dirk G.Sr. VP of Research and Dev.12/10/201536,250
Brockstedt Dirk G.Sr. VP of Research and Dev.12/10/2015745,423
SCHAFER GREGORY WChief Operating Officer12/07/201536,250
SCHAFER GREGORY WChief Operating Officer12/07/2015743,571
Lew JenniferSr. Vice President of Finance12/03/20154,298
Lew JenniferSr. Vice President of Finance12/03/2015156,486
ISAACS STEPHEN TPresident and CEO12/01/201513,000
ISAACS STEPHEN TPresident and CEO12/01/2015727,664
Dubensky Thomas W.Chief Scientific Officer12/01/201564,373
Dubensky Thomas W.Chief Scientific Officer12/01/2015878,104
Greenman William MarinerDirector11/30/201591,950
Lew JenniferSr. Vice President of Finance11/18/20154,298
Lew JenniferSr. Vice President of Finance11/18/2015191,426
ISAACS STEPHEN TPresident and CEO11/16/201513,000
ISAACS STEPHEN TPresident and CEO11/16/2015688,490
Brockstedt Dirk G.Sr. VP of Research and Dev.11/17/201513,220
Brockstedt Dirk G.Sr. VP of Research and Dev.11/16/20152,679
Brockstedt Dirk G.Sr. VP of Research and Dev.11/17/2015545,734
Brockstedt Dirk G.Sr. VP of Research and Dev.11/16/2015204,294
SCHAFER GREGORY WChief Operating Officer11/16/201514,242
SCHAFER GREGORY WChief Operating Officer11/17/201522,008
SCHAFER GREGORY WChief Operating Officer11/16/2015311,168
SCHAFER GREGORY WChief Operating Officer11/17/2015434,072
Dubensky Thomas W.Chief Scientific Officer11/17/201529,753
Dubensky Thomas W.Chief Scientific Officer11/16/201513,747
Dubensky Thomas W.Chief Scientific Officer11/17/2015587,822
Dubensky Thomas W.Chief Scientific Officer11/16/2015301,733
ISAACS STEPHEN TPresident and CEO07/24/2015609
Rogers John E. and Lois A.10% Owner04/20/2015127,500
Rogers John E. and Lois A.10% Owner04/20/2015170,000
Rogers John E. and Lois A.10% Owner04/20/20152,499,986
Morningside Venture (VI) Investments Ltd10% Owner04/20/20157,499,992
OBrien Stephanie MonaghanDirector04/20/201528,900
OBrien Stephanie MonaghanDirector04/20/201528,900
Greenman William MarinerDirector04/20/201551,000
Lew JenniferSr. Vice President of Finance04/20/201534,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CHINOOK THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
FISHER ASSET MANAGEMENT, LLC22,8200.00048%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR CHINOOK THERAPEUTICS INC
STOCK BUYBACKS FOR CHINOOK THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
1.26%
1Q
06/30/2023
12/31/2022
3.35%
2Q
06/30/2023
09/30/2022
5.63%
3Q
06/30/2023
06/30/2022
15.50%
4Q
06/30/2023
03/31/2022
22.72%
5Q
06/30/2023
12/31/2021
38.37%
6Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
1.26%
1Q
12/31/2022
3.35%
2Q
09/30/2022
5.63%
3Q
06/30/2022
15.50%
4Q
03/31/2022
22.72%
5Q
12/31/2021
38.37%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CHINOOK THERAPEUTICS INC
LOADING...